Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ashraf Coovadia and Gayle Sherman.
Connection Strength

2,738
  1. The performance of 5 rapid HIV tests using whole blood in infants and children: selecting a test to achieve the clinical objective. Pediatr Infect Dis J. 2012 Mar; 31(3):267-72.
    View in: PubMed
    Score: 0,408
  2. Oral fluid tests for screening of human immunodeficiency virus-exposed infants. Pediatr Infect Dis J. 2010 Feb; 29(2):169-72.
    View in: PubMed
    Score: 0,353
  3. Evaluation of seven rapid HIV tests to detect HIV-exposure and seroreversion during infancy. J Clin Virol. 2008 Nov; 43(3):313-6.
    View in: PubMed
    Score: 0,320
  4. Prevalence and outcomes of HIV-1 diagnostic challenges during universal birth testing - an urban South African observational cohort. J Int AIDS Soc. 2017 08 29; 20(Suppl 6):21761.
    View in: PubMed
    Score: 0,149
  5. Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study. Lancet HIV. 2017 10; 4(10):e442-e448.
    View in: PubMed
    Score: 0,148
  6. Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges. J Int AIDS Soc. 2017 04 10; 20(1):21436.
    View in: PubMed
    Score: 0,145
  7. Enhancing HIV Treatment Access and Outcomes Amongst HIV Infected Children and Adolescents in Resource Limited Settings. Matern Child Health J. 2017 01; 21(1):1-8.
    View in: PubMed
    Score: 0,143
  8. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA. 2010 Sep 08; 304(10):1082-90.
    View in: PubMed
    Score: 0,092
  9. Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy. Clin Infect Dis. 2009 Feb 15; 48(4):462-72.
    View in: PubMed
    Score: 0,083
  10. Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants. Clin Vaccine Immunol. 2008 Feb; 15(2):388-91.
    View in: PubMed
    Score: 0,076
  11. Evaluation of dried whole blood spots obtained by heel or finger stick as an alternative to venous blood for diagnosis of human immunodeficiency virus type 1 infection in vertically exposed infants in the routine diagnostic laboratory. Clin Vaccine Immunol. 2007 Feb; 14(2):201-3.
    View in: PubMed
    Score: 0,071
  12. Polymerase chain reaction for diagnosis of human immunodeficiency virus infection in infancy in low resource settings. Pediatr Infect Dis J. 2005 Nov; 24(11):993-7.
    View in: PubMed
    Score: 0,066
  13. Can clinical algorithms deliver an accurate diagnosis of HIV infection in infancy? Bull World Health Organ. 2005 Jul; 83(7):559-60.
    View in: PubMed
    Score: 0,064
  14. PMTCT programme--partial assessments can build the picture. S Afr Med J. 2004 Dec; 94(12):934.
    View in: PubMed
    Score: 0,062
  15. PMTCT from research to reality--results from a routine service. S Afr Med J. 2004 Apr; 94(4):289-92.
    View in: PubMed
    Score: 0,059
  16. Low Pretreatment Viral Loads in Infants With HIV in an Era of High-maternal Antiretroviral Therapy Coverage. Pediatr Infect Dis J. 2021 01; 40(1):55-59.
    View in: PubMed
    Score: 0,047
  17. Early antiretroviral treatment of infants to attain HIV remission. EClinicalMedicine. 2020 Jan; 18:100241.
    View in: PubMed
    Score: 0,044
  18. 12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study. Lancet HIV. 2018 12; 5(12):e706-e714.
    View in: PubMed
    Score: 0,041
  19. Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial. Lancet Infect Dis. 2012 Jul; 12(7):521-30.
    View in: PubMed
    Score: 0,026
  20. HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine. AIDS. 2011 Jul 31; 25(12):1461-9.
    View in: PubMed
    Score: 0,024
  21. Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype. J Acquir Immune Defic Syndr. 2011 Jul 01; 57(3):181-9.
    View in: PubMed
    Score: 0,024
  22. Rapid development of antiretroviral drug resistance mutations in HIV-infected children less than two years of age initiating protease inhibitor-based therapy in South Africa. AIDS Res Hum Retroviruses. 2011 Sep; 27(9):945-56.
    View in: PubMed
    Score: 0,024
  23. KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa. PLoS One. 2011 Feb 08; 6(2):e16541.
    View in: PubMed
    Score: 0,024
  24. Induction therapy with protease-inhibitors modifies the effect of nevirapine resistance on virologic response to nevirapine-based HAART in children. Clin Infect Dis. 2011 Feb 15; 52(4):514-21.
    View in: PubMed
    Score: 0,024
  25. Natural killer cells that respond to human immunodeficiency virus type 1 (HIV-1) peptides are associated with control of HIV-1 infection. J Infect Dis. 2010 Nov 01; 202(9):1444-53.
    View in: PubMed
    Score: 0,023
  26. Effect of Maternal HIV-1 Status and Antiretroviral Drugs on Haematological Profiles of South African Infants in Early Life. Open AIDS J. 2010 Aug 12; 4:156-65.
    View in: PubMed
    Score: 0,023
  27. Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis. J Infect Dis. 2010 Apr 15; 201(8):1121-31.
    View in: PubMed
    Score: 0,022
  28. Single-dose nevirapine exposure affects T cell response and cytokine levels in HIV type 1-infected women. AIDS Res Hum Retroviruses. 2009 Oct; 25(10):1049-53.
    View in: PubMed
    Score: 0,022
  29. Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy. AIDS. 2009 Jun 01; 23(9):1097-107.
    View in: PubMed
    Score: 0,021
  30. Cutting Edge: Unusual NK cell responses to HIV-1 peptides are associated with protection against maternal-infant transmission of HIV-1. J Immunol. 2009 May 15; 182(10):5914-8.
    View in: PubMed
    Score: 0,021
  31. Identification of human immunodeficiency virus-1 specific CD8+ and CD4+ T cell responses in perinatally-infected infants and their mothers. AIDS. 2009 Apr 27; 23(7):789-98.
    View in: PubMed
    Score: 0,021
  32. Host CCL3L1 gene copy number in relation to HIV-1-specific CD4+ and CD8+ T-cell responses and viral load in South African women. J Acquir Immune Defic Syndr. 2008 Jul 01; 48(3):245-54.
    View in: PubMed
    Score: 0,020
  33. African infants' CCL3 gene copies influence perinatal HIV transmission in the absence of maternal nevirapine. AIDS. 2007 Aug 20; 21(13):1753-61.
    View in: PubMed
    Score: 0,019
  34. Ultrasensitive human immunodeficiency virus type 1 p24 antigen assay modified for use on dried whole-blood spots as a reliable, affordable test for infant diagnosis. Clin Vaccine Immunol. 2006 Jan; 13(1):152-5.
    View in: PubMed
    Score: 0,017
  35. Vertical HIV transmission in South Africa: translating research into policy and practice. Lancet. 2002 Mar 23; 359(9311):992-3.
    View in: PubMed
    Score: 0,013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.